In an attempt to assess the structural requirements of hexahydro-sila-difenidol for potency and selectivity, a series of analogues modified in the amino group and the phenyl ring were investigated for their affinity to muscarinic M 1 -(rabbit vas deferens), Mr (guinea-pig atria) and Mr (guinea-pig ileum) receptors. All compounds were competitive antagonists in the three tissues. Their affinities to the three muscarinic receptor subtypes differed by more than two orders of magnitude and the observed receptor selectivities were not associated with high affinity. The pyrrolidino and hexamethyleneimino analogues, compounds substituted in the phenylring with a methoxy group or a chlorine atom as weil as p-fluoro-hexahydro-difenidol displayed the same affinity profile as the parent compound, hexahydro-sila-difenidol: M 1 = M 3 > M 2 • A different selectivity patternwas observed for p-fluoro-hexahydro-sila-difenidol: M 3 > M 1 > M 2 • This compound exhibited its highest affinity for M 3 -receptors in guinea-pig ileum (pA 2 = 7.84), intermediate affinity for M 1 -receptors in rabbit vas deferens (pA 2 = 6.68) and lowest affinity for the Mrreceptors in guinea-pig atria (pA 2 = 6.01). This receptor selectivity profile of p-fluoro-hexahydro-sila-difenidol was confirmed in ganglia (M 1 ), atria (M 2 ) and ileum (M 3 ) of the rat. Furthermore, dose ratios obtained with either pirenzepine (Mt) or hexahydrosila-difenidol (M 2 and M 3 ) and the p-fluoro analogue used in combination suggested that the antagonism was additive, implying mutual competition with a single population of muscarinic receptor subtypes. These results indicate that p-fluoro-hexahydro-sila-difenidol represents a valuable tool for characterization of muscarinic receptor subtypes.
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lntroduction
Radioligand binding and functional data, have allowed the clear demonstration that there are at least three major subtypes of muscarinic recep-
• To whorn all correspondence should be addressed: Departrnent of Pharrnacology, University of Frankfurt, TheodorStern-Kai 7, Gebäude 75A, D-6000 FrankfurtjM, F.R.G. Eglen and Whiting, 1986; Mitchelson, 1988; Mutschier et al., 1988) . M 1 -receptors are found in high density in neuronal tissues such as autonotnie ganglia, cerebral cortex. and hippocampus, whereas M 2 -and M 3 -receptors are mainly present in lower brain areas and in peripheral effector organs such as heart (M 2 ), smooth muscle (M 3 ) and glands (M 3 ). This pharmacological subclassification of musearlnie receptors is based mainly on the different affinities of selective antagonists such as pirenzepine (M 1 > M 2 == M 3 ) (Hammer et al., 1980; Hammer and Giachetti, 1982; Doods et al., 1987; Lambrecht et al., 1988c; Waelbroeck et al., 1986; , methoctramine and AF-DX 116 (M 2 > M 1 > M 3 ) (Melchiorre et al., 1987; Micheletti et al., 1987; Melchiorre, 1988; Waelbroeck et al., 1988) , and hexahydro-sila-difenidol (M 1 == M 3 > M 2 ) (Fuder et al., 1985; Giraldo et al., 1988; Lambrecht et al., 1988a; Waelbroeck et al., 1988) . More recently, differences in the amino acid sequences of musearlnie receptor subtypes have been demonstrated by cloning, sequencing and expression of complementary DNA encoding these receptors (Kerlavage et al., 1987; Peraha et al., 1987; Akiba et al., 1988; Brann et al., 1988) . The antagonist binding properlies of the individual cloned receptors (ml, m2 and m3) and their pattems of expression in various tissues correspond closely to those of the pharmacologically defined M 1 -, M 2 -and M 3 -receptors, respectively (Peralta et al., 1987; Akiba et al., 1988; Buckley et al., 1989) .
Hexahydro-sila-difenidol (!, fig. 2 ) was discovered in the course of structure-activity (selectivity) relationship studies of a series of difenidol and sila-difenidol analogues ( fig. 1 ) (for recent reviews, see Tacke and Becker, 1987; Mutschier et al., 1988) . Structurally, these molecules consist of a central carbinol (silanol) carbon (silicon) atom carrying an OH group, two ring systems and an aminoalkyl group [(CH 2 ) 0 -NR 2 ] (figs. 1 and 2). It was found in preceding investigations that the potency and selectivity of the difenidol and sila-9 HO--El-(CH2) -ND difenidol analogues are controlled by the nature of the central atom (EI= C, Si) and the structure of the ring system 'R' bound to this atom, the absolute configuration at the central atom and the length of the alkylene chain (Tacke et al., 1986; Lambrecht et al., 1988b; . The main goal of the present study was to characterize the structural demands for potency and selectivity among hexahydro-sila-difenidol analogues modified in the cyclic amino group and in the phenyl ring system. Consequently, the antagonist affinities of compounds ~- §, 7a and 7b ( fig. 2 ) were determined and compared with those obtained for the parent compound hexahydro-sila-difenidol (!) and the reference drugs pirenzepine and methoctramine. The receptors studied were M 1 -receptors in rabbit vas deferens (Eltze, 1988; , cardiac M 2 -receptors in guinea-pig atria and smooth muscle M 3 -receptors in guinea-pig ileum. Furthermore, we report on in vitro experiments with hexahydro-sila-difenidol and its p-fluoro derivative 7b in ganglionic (M 1 ), atrial (M 2 ) and ileal (M 3 fpreparations of the rat. The agonist independence of the antagonism was investigated to verify the mechanism of action of p-fluoro-hexahydro-sila-difenidol (7b) (Lambrecht et al., 1988a) . In addition, antagonist combination experiments were carried out and analyzed according to the dose-ratio method of Paton and Rang (1965) . The results are discussed in terms of their implications for musearlnie receptor classification.
Materials and methods

Rabbit isolated vas deferens
Experiments on rabbit isolated vas deferens were performed as described by Eltze (1988) .
Male New Zealand white rabbits were killed by i.v. injection of pentobarbital sodium (120 mgjkg). Vasa deferentia were removed and segments of 1.5 cm length were suspended in 7 ml organ baths containing modified Krebs buffer (composition in mM: NaC1118.0, KC14.7, CaC1 2 2.5, MgS0 4 0.6, KH 2 P0 4 1.2, NaHC0 3 25.0, ( + )-glucose 11.1; 10-6 M yohimbine was included to block a 2 -adrenoceptors) gassed with 95% 02-5% co2 at 31° C. A resting tension of 0.75 g was applied and isometric twitch contractions were elicited by electrical field stimulation (0.05 Hz, 0.5 ms, 30 V). These effects were concentration dependently inhibited by the M 1 -selective agonist, 4-(4-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium iodide (4-Cl-McN-A-343) and recorded as with the atria.
Isolated atria and ileum of the guinea-pig and rat
Adult guinea-pigs and Wistar rats of either sex were killed by a blow to the head. Left atria and ileum were set up under 0.5 g tension in 6 ml organ baths containing oxygenated (95% 0 2 -5% C0 2 ) Tyrode solution (32 o C; composition in mM: NaCl 137.0, KCI 2.7, CaC1 2 1.8, MgC1 2 1.05, NaHC0 3 11.9, NaH 2 P0 4 0.42, ( + )-glucose 5.6).
The atria were paced at 2 Hz, with bipolar platinum electrodes, square-wave pulses of threshold (+50%) valtage and 3 ms pulse width. Negative inotropic responses to the cumulative addition of the muscarinic agonist, arecaidine propargyl ester (Mutschler and Hultzsch, 1973; Moseret al., 1989) were measured as changes in isometric ten-73 sion. A force-displacement transducer connected to a Heilige amplifier and a multichannel recorder were used for these measurements. Strips of ileal longitudinal muscle (1.5 cm length) were prepared according to Paton and Zar (1968) . The tissue responses to the cumulative addition of arecaidine propargyl ester were measured as isotonic contractions and recorded as wi th the atria.
3. Jsolated superior cervical ganglion of the rat
Experiments on ganglia were performed as described by Brown et al. (1980) . Superior cervical ganglia were excised from male Sprague-Dawley rats (200-300 g) that had been anaesthetized with urethane (1.2 gjkg i.p.). Each ganglion was desheathed, suspended vertically in a separate heated chamber (36 ° C) and superfused with oxygenated (95% 0 2 -5% C0 2 ) Krebs solution (1 mljmin) which consisted of (mM): NaCl 124.0, KCI 3.0, NaHC0 3 26.0, NaH 2 P0 4 1.25, CaC1 2 2.0, MgC1 2 2.0 and ( + )-glucose 10.0. The muscarine-induced depolarization (EC 50 = 40 nM) was recorded differentially, via two calomel electrodes, between the ganglion and its postganglionic trunk. The DC potentials were amplified by microvoltmeters (Keithley 177) and were monitared on a chart recorder. Concentration-response curves were made with single doses of muscarine applied at 20-45 min intervals, followed by a washaut phase until the baseline was reached.
Antagonist affinities
The tissues were allowed to equilibrate for 30-60 min. Concentration-response curves to the agonists were obtained before and after adding an antagonist. EC 50 values were determined for the control and the antagonist-shifted concentration-response curves. Unless indicated otherwise (table 1), at least three concentrations (log interval = 0.48) of antagonists were tested in the three tissues, allowing 15-60 min equilibration time. Each concentration of antagonist was tested 3-5 times and the ratios of agonist molar EC 50 values obtained in the absence and presence of antagonists were calculated. Schild plots were made, using linear regression, by the method of least squares. The slopes of these plots were not significantly (P > 0.05) different from unity. The pA 2 values were thus estimated by fitting the best straight line with a slope equal to unity (Tallarida et al., 1979) .
Antagonist combination experiments
The effects of p-fluoro-hexahydro-sila-difenidol (7b) in combination with pirenzepine in rabbit vas deferens or hexahydro-sila-difenidol (!) in guineapig atria and ileum were investigated on the basis of dose ratio analysis (Paton andRang, 1965) . The concentration-response curves to the agonists in these experiments were made under control eonditions then in the presenee of pirenzepine (SO nM), hexahydro-sila-difenidol (atria: 3 ~tM; ileum: 100 nM) or p-fluoro-hexahydro-sila-difenidol (vas deferens: 1 p.M; atria: 3 J.LM; ileum: 100 nM) alone or with the respeetive two antagonists eombined. The eontaet time for antagonists was always 30 min and the agonists used were 4-Cl-MeN-A-343 (vas deferens) and areeaidine propargyl ester (atria and ileum), respeetively. The experimental data for individual antagonist applications were used to ealculate dose ratios (DR) expected for the eombination for two models: expeeted single-site = DR 1 + DR 2 -1 and expeeted independent sites = DR 1 X DR 2 • Thesedose ratios were eompared with the experimentally observed combined mean dose ratios.
6. Statistics
The data are presented as means ± S.E.M. of 8-18 experiments with eaeh preparation. The differenees between mean values were tested for statistieal signifieanee (P < 0.05) by means of Student's t-test.
Drugs
Carbaehol (earbamylcholine ehloride), d,lmusearine ehloride and yohimbine hydroehloride (Sigma); oxotremorine sesquifumarate (Ega-Chemie); pirenzepine dihydrochloride (Boehringer Ingelheim); methoetramine tetrahydroehloride (kindly provided by Dr C. Melchiorre, University of Bologna, ltaly); MeN-A-343 (4-(3-ehlorophenylcarbamoyloxy)-2-butynyltrimethylammonium ehloride) (Serva); areeaidine propargyl ester (Mutschler and Hultzseh, 1973) , 4-Cl-McN-A-343 (4-(4-ehlorophenylcarbamoyloxy)-2-butynyltrimethylammonium iodide) (Nelson et al., 1976) as well as compounds ! - §, 7 a and 7b were syn thesized in our laboratories (Tacke et al., 1985: !; silicon eompounds f-Q and 7b were prepared by analogy to the synthesis of theparent eompound! and the earbon eompound 7a was prepared by analogy to the synthesis of hexahydro-difenidol; unpublished results). The other chemieals were of reagent grade and were used as purchased.
Compounds !-. §, 7a and 7b possess a eentre of ehirality and therefore exist1n two enantiomers. They were used as racemates because indications were found that the enantiomers of silanals of this type may raeemize in aqueous solution (Tacke et al., 1987) .
Results
The inhibition of twitch eontraction indueed by 4-Cl-MeN-A-343 (EC 50 = 250 nM) in field-stimulated rabbit vas deferens and the muscarine-indueed depolarization in rat ganglia as weil as the arecaidine propargyl ester-mediated responses in atria and ileum of guinea-pigs and rats were antagonized by eompounds !- §, 7a and 7b. The antagonists produced coneentration-dependent parallel shifts of the agonist eoncentration-response eurves without either basal tension or maximum response being affected at the concentration range tested. The Schild plots were linear and the slopes were not significantly different from unity (P > 0.05). Thus, all compounds were apparently simple competitive muscarinie antagonists. These resul ts are summarized in tables 1 and 2.
Antagonist affinities in rabbit vas deferens and guinea-pig atria and ileum
Compounds !- §, 7a and 7b showed quite wide variations in their affinities To the musearlnie reeeptors in vas deferens, atria and ileum, their pA 2 values (table 1) differing by more than two orders of magnitude. As with the parent eompound, hexahydro-sila-difenidol (!), the derivatives ~- § and 7a exhibited similar affinities at reeeptors TABLE 1 Affinity profiles of pirenzepine, methoctramine and compounds !-~. 7a and 7b at muscarinic M 1 -receptors in rabbit vas deferens (RVD) and at M 2 -receptors in guinea-pig atria (GPA) as well as at M 3 -receptorsin guinea-pig ileum (GPI). pA 2 values and slopes of Schild plots (in parentheses) were calculated as described in Methods (antagonist affinities) and are presented as means ± S.E.M. The ratios of affinity constants are given as a measure of receptor selectivity. These values were calculated from the antilogs of the differences between respective pA 2 values.
pA2
Selectivity ratios Eltze and Figala (1988) and Lambrecht et al. (1988a) . b Hexahydro-sila-difenidol. c Only one or two concentrations of the antagonists were investigated due to the negative inotropic effects of the antagonists themselves at higher concentrations:
J (11'M), ~ (31'M), ~ (3 and 10 I'M), ~ (1 MM), 7b (1 and 31'M). The pA 2 values were therefore determined from the individual dose ratios according to Tallarida et al. (1979) . d pA~values and slopes of Schildplotstaken from . e A pA 2 value of 6. 95 ± 0.04 was obtained using McN -A-343 as agonist. r pA 2 values of 7.83 ± 0.08 and 7.89 ± 0.07 were obtained using carbachol and oxotremorine, respectively. as agonists.
TABLE 2
The affinities of hexahydro-sila-difenidol (!) and p-fluoro-hexahydro-sila-difenidol (7b) for muscarinic M 1 -receptors in rat superior cervical ganglia (RG), M 2 -receptors in rat atria (RA) and M 3 -receptors in rat ileum (RI). pA 2 values and slopes of Schild plots (in parentheses) are presented as means ± S.E.M. The ratios of aHinity constants are given as a measure of receptor selectivity. These values were calculated from the antilogs of the differences between respective pA 2 values. • The pA 2 value observed in this preparation for pirenzepine was 8.30 (Lambrecht et al., 1988c) . present in the vas deferens and ileum (dotted line in fig. 3, panel b ), but the pA 2 values obtained in atria were much lower. This selectivity profile of the compounds is demonstrated by the selectivity ratios given in table 1 and is illustrated in fig. 3 .
A different selectivity pattem was observed for p-fluoro-hexahydro-sila-difenidol (7b ). This antimuscarinic agent exhibited the highest affinity (pA 2 = 7.84) for the receptors in the ileum, an intermediate affinity for the receptors in vas deferens (pA 2 = 6.68) and lowest affinity for the cardiac receptors (pA 2 = 6.01 ).
Antagonist affinities in rat ganglia, atria and ileum
Hexahydro-sila-difenidol (!) and i ts p-fluoro derivative 7b were tested in three isolated preparations of the rat: superior cervical ganglia (M 1 ), atria (M 2 ) and ileallongitudinal muscle (M 3 ). The pA 2 values and corresponding Schild slopes are shown in table 2. Although there were some quantitative differences, both compounds showed qualitatively the same receptor selectivity profile as was found in rabbit vas deferens and guinea-pig atria and ileum ( table 1 ); hexahydro-sila-difen-
Combination experiments
The mutual competition between p-fluorohexahydro-sila-difenidol (7b) and pirenzepine or TABLE 3 Summary of dose ratio analysis from the P""fluoro-he'lahydrosila-difenidol (7b) combination e'lperiments. Each dose ratio (DR) is the mean± S.E.M. and the number of observations is given in parentheses. • DR 1 + DR 2 -1. b DR 1 x DR 2 • c Hexahydro-sila-difenidol.
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the parent compound! was investigated in rabbit vas deferens and guinea-pig atria and ileum, respectively, on the basis of dose ratio analysis (Paton and Rang, 1965) . The results of these experiments are summarized in table 3. The combined dose ratios obtained experimentally in the three preparations were very close to those calculated for two antagonists acting at a single site. The results are not consistent (P < 0.05) with a multiplication of dose ratios which would be expected if two antagonists interacted at independent sites.
Discussion
General considerations
The presynaptic musearlnie receptors in rabbit vas deferens and the postsynaptic receptors in guinea-pig atria and ileum have been weil established tobelang to different subclasses: ganglionic M 1 -, cardiac M 2 -and smooth musclejglandular M 3 -receptors (Eltze, 1988; Eltze and Figala, 1988; Lambrecht et al., 1988a-c; ). This heterogeneity is based mainly on the different affinities of selective antagonists such as
The present study concemed the effects of changing the size of the cyclic amino group ( compounds ~ and ~) and introducing substituents in the phenyl ring ( compounds ~-Q, 7b) of hexahydro-sila-difenidol (1) as weil as offeplacing the central silicon atom of compound 7b by a carbon atom (compound 7a) on muscarinicpotency.
The principal conclusions drawn from these experiments are that: (1) compounds !-Q, 7a and 7b act as competitive musearlnie antagonists in rabbit vas deferens as weil as in guinea-pig atria and ileum. They produced an antagonism that was reversible and surmountable and their apparent affinity in each tissue appeared tobe independent of the concentrations used. Thus, Schild analysis yielded slopes which were not significantly different from unity (table 1) . The affinity constants of p-fluoro-hexahydro-sila-difenidol (7b) in rabbit vas deferens and guinea-pig ileum were independent of. the agonist used (rabbit vas deferens:
McN-A-343 = 6.95; 4-Cl-McN-A-343 = 6.68; guinea-pig ileum: arecaidine propargyl ester = 7.84; carbachol = 7.83; oxotremorine = 7.89) (table 1). In addition to the data obtained from the Schild analysis, combination sturlies (table 3) showed compound 7b to act in a manner indistinguishable from 'classical' competitive antagonists. (2) Structural variations in the hexahydrosila-difenidol molecule led to new musearlnie antagonists which exhibit a qualitatively andjor quantitatively different spectrum of receptor selectivity to the parent compound. The selectivity observed does not appear to be associated with high affinity as there are less potent compounds with appreeiable selectivity (compounds ~- §; table 1 and fig. 3 ).
Structure-selectivity re/ationships
The influence of the ring size of the cyclic amino group on potency and seleetivity ean be demonstrated by eomparison of eompounds !-~. As can be seen from the data in table 1 the affinity to the three musearlnie reeeptor subtypes depends on the nature of the heterocyclie ring system and varies up to about 6-fold. Compound ~' eontaining a pyrrolidino ring, shows nearly the same affinity to MI-, M 2 -and M 3 -reeeptors as the parent compound, hexahydro-sila-difenidol (!). In contrast, ring extension to the hexamethyleneimino derivative ~ results in a deerease in affinity for all subtypes. However, the influence of the size of the cyclic amino group on seleetivity is moderate as compounds ~ and ~ showed the same selectivity pattern as the parent compound !: MI=::: M 3 > M 2 • Therefore eompounds !-l deviate significantly from the line of equivalence when the pA 2 values in guinea-pig atria are compared to those in the ileum and rabbit vas deferens, respectively ( fig. 3 , panels a and c).
Comparison of compounds !, ~ § and 7b defines the effect of substituents in the phenYJ ring of hexahydro-sila-difenidol. Either a methoxy substituent in the ortho or para position ( compounds ~ and ,2) or a para-chloro substituent (compound §) reduces the affinity to the musearlnie receptors up to more than one order of magnitude (table 1) fig. 3} . This novel selectivity profile of 7b is based on the fact that the para-fluoro substituent Ieads to a decrease in Mc and M 2 -antimuscarinic potency while only slightly affecting the affinity towards Mrreceptors.
The pA 2 values determined for p-fluoro-hexahydro-sila-difenidol (7b) in rat atria and ileum (5.99 and 7.88, respectively; table 2) were very close to that found in the corresponding guinea-pig tissues (6.01 and 7.84, respectively; table 1). The pA 2 value observed for compound 7b at M 1 -receptors in rat superior cervical ganglia(7.21 using muscarine as agonist; table 3) was slightly higher than that found in rabbit vas deferens (6.68 using 4-Cl-MeN-A-343 and 6.95 using McN-A-343 as agonists; table 1). However, the data obtained with the three rat tissues show that the reeeptor seleetivity profile of p-fluoro-hexahydro-sila-difenidol (M 3 > M 1 > M 2 ) is speeies-independent. This also holds for the parent compound, hexahydrosila-difenidol (M 1 :::::: M 3 > M 2 ; tables 1 and 2).
Replacement of the central silicon atom in eompound 7b by a earbon atom (7b---+ 7a) inereased the affinity for M 1 -receptors in rabbit vas deferens as well as for cardiae M 2 -receptors in guinea-pig atria by factors of 8 and 4, respectively, whereas the affinity to M 3 -receptors in guinea-pig ileumwas not changed significantly (P > 0.05) (table 1). Thus, the seleetivity profile of p-fluorohexahydro-difenidol (7a) is similar to that of the silicon compounds !- § ( fig. 3 ), but differs from that of its sila analogue 7b). This is a further example indicating that sila substitution (C/Si exchange) may be a useful tool to improve receptor selectivity (for a recent review on CjSi-bioisosterism, see Tacke and Linoh, 1989) .
In conclusion this report describes structure-activity relationships of antimuscarinics related to hexahydro-sila-difenidol (!). The antimuscarinic potency and selectivity in this series of compounds (!-Q, 7a and 7b; fig. 2 ) is controlled by the Substitution pattem of the phenyl moiety, the structure of the cyclic amino group and the nature of the central atom 'EI' (carbon or silicon). Compounds with qualitatively andjor quantitatively different receptor selectivity profiles were obtained. Among the antimuscarinic agents tested in this study, p-fluoro-hexahydro-sila-difenidol (7b) is the only compound which showed appreciable M 3 -receptor selectivity (M 3 > M 1 > M 2 ). Its affinity profile is different from that of the parent compound, hexahydro-sila-difenidol (!) (M 1 == M 3 > M 2 ), and its selectivity for Mrreceptors is comparable to that of pirenzepine for M 1 -and methoctramine for M 2 -receptors ( fig. 3 ). pFluoro-hexahydro-sila-difenidol (7b) therefore represents a useful tool for the subclassification of muscarinic receptors.
